Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET-letter

Research output: Contribution to journal › Article

Cite this

@article{089db3bae7d84eaf99467c9a545aefa1,

title = "Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET-letter",

author = "Lorenza Rimassa and Jordi Bruix and Massimo Broggini and Armando Santoro",

year = "2013",

month = aug,

day = "1",

doi = "10.1158/1078-0432.CCR-13-1321",

language = "English",

volume = "19",

pages = "4290",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "15",

}

TY - JOUR

T1 - Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET-letter

AU - Rimassa, Lorenza

AU - Bruix, Jordi

AU - Broggini, Massimo

AU - Santoro, Armando

PY - 2013/8/1

Y1 - 2013/8/1

UR - http://www.scopus.com/inward/record.url?scp=84881242876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881242876&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-13-1321

DO - 10.1158/1078-0432.CCR-13-1321

M3 - Article

C2 - 23766362

AN - SCOPUS:84881242876

VL - 19

SP - 4290

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 15

ER -